INS and Insulin resistance: Chronic hyperglycemia in patients with T2DM leads to peripheral insulin resistance, whereas impaired insulin signaling pathways in the brains of patients with AD lead to “brain insulin resistance,” both of which are closely related to mitochondrial dysfunction and OS (Du et al., 2022; Zhang et al., 2023).